Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations
ClinicalTrials.gov study NCT01131325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
ClinicalTrials.gov study NCT00499889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00114959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML
ClinicalTrials.gov study NCT02311998. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
ClinicalTrials.gov study NCT00038675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Nilotinib in CML-CP
ClinicalTrials.gov study NCT03332511. IPD Sharing: NO. Countries: 0. Publications: 1.
Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)
ClinicalTrials.gov study NCT02480608. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01077544. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis
ClinicalTrials.gov study NCT06042660. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)
ClinicalTrials.gov study NCT00405054. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
ClinicalTrials.gov study NCT06514534. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase I
ClinicalTrials.gov study NCT02108951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML
ClinicalTrials.gov study NCT04151706. IPD Sharing: NO. Countries: 1. Publications: 0.
Pegasys in Patients With Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01392170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Trans
ClinicalTrials.gov study NCT00548847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
ClinicalTrials.gov study NCT07354074. IPD Sharing: YES. Countries: 0. Publications: 0.
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
ClinicalTrials.gov study NCT00493181. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT02736721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT00813124. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00067028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.